Takeda Clinical Trials

Clinical trials sponsored by Takeda — phases, conditions and reported results. Data from ClinicalTrials.gov.

• A Study of Leuprolide Acetate Depot in Children With Central Precocious Puberty
  Phase 4 · Central Precocious Puberty · Completed · Jan 13, 2026
• Long-Term Safety and Antibody Persistence of TDV and the Impact of a Booster Dose
  Phase 3 · Dengue Fever · Completed · Jun 12, 2025
• A Study of TAK-861 in People With Narcolepsy Type 1
  Phase 3 · Narcolepsy Type 1 · Completed · Jul 16, 2026
• A Study of Intrathecal SHP611 in Children With Metachromatic Leukodystrophy
  Phase 2 · Metachromatic Leukodystrophy · Completed · Jun 6, 2024
• A Study of TAK-103 in Adult With Solid Tumors
  Phase 1 · Solid Tumors · Terminated · Jul 7, 2026
• First-in-Human Study of TAK-280 in Participants With Solid Tumors
  Phase 1/2 · Unresectable Locally Advanced or Metastatic Cancer · Terminated · Jul 7, 2026
• A Study of Ixazomib and Ibrutinib in Relapsed/Refractory Mantle Cell Lymphoma
  Phase 1/2 · Mantle-Cell Lymphoma · Completed · Jan 8, 2024
• A Study of TAK-771 in Japanese Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CI
  Phase 3 · Chronic Inflammatory Demyelinating Polyradiculoneuropathy · Completed · Mar 18, 2025
• A Study of TAK-853 in Adult Participants With Folate Receptor Alpha-Positive Advanced Ovarian Cancer And Other
  Phase 1/2 · Ovarian Cancer · Active, not recruiting · Jun 16, 2026
• A Study of Intravenous Vedolizumab Administered Every 4 Weeks in Japanese Participants With Moderate to Severe
  Phase 3 · Ulcerative Colitis · Active, not recruiting · Jun 15, 2026
• A Study of Brentuximab Vedotin in Combination With Cyclophosphamide, Doxorubicin (Hydroxydaunorubicin), Predni
  Phase 2 · Lymphoma · Active, not recruiting · Jun 12, 2026
• A Study of TAK-881 and HyQvia in Healthy Adults
  Phase 1 · Healthy Volunteers · Completed · May 11, 2026
• A Study of Soticlestat as an Add-on Therapy in Children and Adults With Dravet Syndrome or Lennox-Gastaut Synd
  Phase 3 · Dravet Syndrome · Terminated · Jun 9, 2026
• A Study of TAK-341 in Treatment of Multiple System Atrophy
  Phase 2 · Multiple System Atrophy · Completed · Jun 2, 2026
• A Study of Dengue Vaccine in Healthy Children, Teenagers and Adults in India
  Phase 3 · Healthy Volunteers · Completed · May 29, 2026

Trials by company

PfizerMerck (MSD)RocheNovartisAstraZenecaJohnson & Johnson (Janssen)Bristol Myers SquibbSanofiGSKEli LillyAbbVieAmgenBayerBoehringer IngelheimNovo NordiskTakedaGilead SciencesModernaBioNTechRegeneronVertexBiogenDaiichi SankyoAstellas PharmaEisaiOtsukaServierIncyteCelltrionSamsung BioepisHanmi PharmaceuticalYuhan

All trials